Crowdonomics
All companies
LULLAFEED™ logo

LULLAFEED™

Operating

Innovative Therapeutix, Inc.

Retail · Product · Founded 2017

Visit website

For when you baby needs you the most

Valuation cap ⓘ
$4.0M
As of Jul 2024 · from LULLAFEED Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$298,471
Across 1 round since 2024

Financials

FY2021–FY2024 · from SEC filings · hover any figure for its source
$0
−$101K
2021
$0
−$483K
2022
$0
−$483K
2023
$0
−$241K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
-$101,457
-$483,445
-$483,445
-$240,517
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$443,485
$35,049
$35,049
$341,923
Accounts receivable
$0
$0
$0
$0
Total assets
$443,485
$35,049
$35,049
$341,923
Short-term debt
$0
$499,890
$499,890
$0
Long-term debt
$574,882
$125,000
$125,000
$673,271
Total liabilities
$574,882
$624,890
$624,890
$673,271
Other
Headcount
—
0
—
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$4.0M
Valuation cap
LULLAFEED Future Equity SAFE 1

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

LULLAFEED Future Equity SAFE 1ClosedReg CF · SAFE · via WeFunder
Raised $298.5K / $500KInvestors 96Valuation cap $4M

Team

2 people
Michael Detmer
Chief Executive Officer
Rebekah R Gossom
Chief Clinical Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 3 annual reports (FY2023–FY2025)

96 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMar 14, 20250001670254-25-000184
    EDGAR
  • Form CMar 12, 20240001670254-24-000209
    EDGAR
  • Form DJan 5, 20230001908403-23-000001
    EDGAR
  • Form DFeb 2, 20220001908403-22-000001
    EDGAR
Source: ManualCIK 0001908403

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.